On February 28, 2015, the sixth subject was treated in our ongoing study of MDMA-assisted therapy for social anxiety in 12 adults on the autism spectrum. Now halfway through treatment, this study is exploring whether MDMA combined with therapy can enhance functional skills and quality of life in autistic adults with social anxiety. Sponsored by MAPS, this is a collaborative study between MAPS, the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, and researchers at Stanford University. “As the first study of its kind in this population, we’re excited for the second half of this study,” said MAPS Clinical Research Scientist Berra Yazar-Klosinski, Ph.D. “Preliminary results from the primary outcome measure on social anxiety are promising.” Learn more…